Enovis Corp (ENOV) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Enovis Corp : Jefferies Cuts Target Price to $70 From $75
ReutersMar 3 03:44 ET
A Quick Look at Today's Ratings for Enovis Corp(ENOV.US), With a Forecast Between $46 to $75
Moomoo NewsFeb 28 08:00 ET · Ratings
A Quick Look at Today's Ratings for Enovis Corp(ENOV.US), With a Forecast Between $58 to $75
Moomoo NewsFeb 27 08:00 ET · Ratings
Express News | Enovis Corporation : Wells Fargo Cuts Target Price to $59 From $62
ReutersFeb 27 06:15 ET
Enovis Price Target Cut to $64.00/Share From $65.00 by Needham
Dow JonesFeb 27 05:16 ET · Ratings
Enovis Is Maintained at Buy by Needham
Dow JonesFeb 27 05:16 ET · Ratings

Comments

Moomoo AI

Feb 26, 2024 07:55

The company's use of debt is seen as risky due to its EBIT loss and the liabilities it has. The balance sheet is not considered strong, but it could improve over time. The stock is considered quite risky.

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

1

Moomoo AI

Feb 25, 2024 17:55

Needham analysts predict Enovis's new products, orthopedic market strength, and the Lima acquisition will exceed 2024 consensus. They also foresee Paragon 28 returning to roughly 20% revenue growth in 2024 due to new bunion-focused products, supply chain enhancements, and sales force growth.

Needham Sees Orthopedics Market Slowing; Favors Enovis, Paragon 28

Moomoo AI

Dec 5, 2023 05:10

Enovis CEO Matt Trerotola praised Shirley, Vogt, and Ross for their roles in the company's growth. He highlighted Shirley's influence on Enovis's transformation to a medtech firm, Vogt's contribution to the U.S. surgical business growth, and Ross's work in ensuring sustained growth in the P&R segment.

Press Release: Enovis Announces Business Segment Leadership Transition Plan

Moomoo AI

Nov 30, 2023 07:01

Enovis' falling revenue and absent profits might have led to a drop in share price. Viewing the total shareholder return and recent share price rise, the company may suggest investment potential if it shows sustainable long term growth.

Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Nov 3, 2023 09:26

Enovis's rise in liabilities and recent EBIT loss spark concerns about its debt use and future profitability. With a negative free cash flow of US$106m over the past year, the company's financial risk is evident. Balance sheet situation calls for caution due to dubious circumstances.

Would Enovis (NYSE:ENOV) Be Better Off With Less Debt?

ENOV Enovis Corp

Trade Overview

Capital Trend

News

Comments

Trending Stocks